PUBLISHER: Global Insight Services | PRODUCT CODE: 1598964
PUBLISHER: Global Insight Services | PRODUCT CODE: 1598964
The genome editing market is anticipated to expand from $10.1 billion in 2023 to $35.5 billion by 2033, reflecting a CAGR of approximately 13.1%.
The genome editing market encompasses the technologies and services aimed at modifying genetic material to achieve desired traits or outcomes. This market includes CRISPR, TALENs, and ZFNs technologies, along with applications in healthcare, agriculture, and biotechnology. It supports advancements in disease treatment, crop improvement, and scientific research, driving innovation in genetic engineering and personalized medicine.
The genome editing market is experiencing robust growth, driven by advancements in CRISPR technology and increasing applications in healthcare. The therapeutics segment leads the market, particularly in gene therapy and regenerative medicine, due to its potential to treat previously incurable diseases. Agricultural biotechnology emerges as the second-highest performing sub-segment, fueled by the need for improved crop yields and resistance to pests and climate change.
Regionally, North America dominates the market, benefiting from strong research infrastructure, significant funding, and supportive regulatory frameworks. Europe follows closely, propelled by strategic collaborations and a focus on precision medicine. Within these regions, the United States and Germany are key contributors, given their emphasis on innovation and robust biotech ecosystems. The Asia-Pacific region is poised for rapid growth, driven by rising investments in research and development and increasing adoption of genome editing technologies in agriculture and healthcare. This growth trajectory underscores the lucrative opportunities for stakeholders across the genome editing landscape.
Key Companies
Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Beam Therapeutics, Precision Bio Sciences, Sangamo Therapeutics, Cellectis, Horizon Discovery, Caribou Biosciences, Graphite Bio, Poseida Therapeutics, Tessera Therapeutics, Prime Medicine, Mammoth Biosciences, Synthego, Inscripta, Locus Biosciences, e Genesis, Pairwise Plants, Apexigen, Scribe Therapeutics, Verve Therapeutics, Rejuvenate Bio, Metagenomi, Chroma Medicine
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.